Evidence map›Paper›PMID 25894383›Full record

ArticleJournal of molecular medicine (Berlin, Germany)2015

p55γ functional mimetic peptide N24 blocks vascular proliferative disorders.

Jiaojiao Guo, Ning Xie, Geng Li, Yan Zhang, Fengxiang Lv, Sile Guo, Yuanqing Feng, Chun-Mei Cao, Rui-Ping Xiao

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular medicine (Berlin, Germany), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jiaojiao GuoInstitute of Molecular Medicine, Peking University, Beijing, 100871, China.
Ning XieInstitute of Molecular Medicine, Peking University, Beijing, 100871, China.
Geng LiInstitute of Molecular Medicine, Peking University, Beijing, 100871, China.
Yan ZhangInstitute of Molecular Medicine, Peking University, Beijing, 100871, China.
Fengxiang LvInstitute of Molecular Medicine, Peking University, Beijing, 100871, China.
Sile GuoInstitute of Molecular Medicine, Peking University, Beijing, 100871, China.
Yuanqing FengInstitute of Molecular Medicine, Peking University, Beijing, 100871, China.
Chun-Mei CaoInstitute of Molecular Medicine, Peking University, Beijing, 100871, China. caochunmei@pku.edu.cn.
Rui-Ping XiaoInstitute of Molecular Medicine, Peking University, Beijing, 100871, China. xiaor@pku.edu.cn.
Peking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledProliferation and migration disorders of vascular smooth muscle cells (VSMCs) contribute to the pathogenesis of proliferative cardiovascular diseases. Although, over the past two decades, a large panel of drugs has been developed for targeting VSMC proliferation, cardiovascular disease remains the leading cause of death worldwide. Thus, there is a compelling need to identify novel signaling pathways and molecules controlling VSMC proliferation and migration, to provide not only mechanistic insights but also safe and effective therapies for the treatment of cardiovascular diseases. Our recent studies have demonstrated that p55γ, a regulatory subunit of phosphoinositide 3-kinase, functions as an endogenous brake on VSMC proliferation. Here, we demonstrate that the small peptide N24, the first 24 amino acids of the NH2 terminus of p55γ, is a functional mimetic which negatively regulates VSMC proliferation and migration. Specifically, luminal delivery of adenovirus expressing N24 or local administration of Tat transactivator protein (TAT)-tagged N24 by pluronic gel alleviates neointimal formation following balloon injury in rat carotid arteries. Enforced expression of N24 suppresses the proliferation and migration of VSMCs induced by serum- or platelet-derived growth factor-BB. Mechanistically, N24 induces cell cycle arrest via activating the p53-p21 signal pathway, without triggering cell death. N24 interacts with and stabilizes p53 by blocking its ubiquitin-dependent degradation, subsequently promotes p21 transcription, and arrests cell cycle progression. Indeed, knockdown of p21 or p53 abrogates the N24-mediated cell growth arrest. Thus, N24 is a p55γ mimetic inhibiting VSMC proliferation as well as migration, thereby conferring important therapeutic implications for anti-proliferative treatment. KEY MESSAGE: • N24 attenuates balloon injury-induced neointimal formation. • Overexpression of N24 inhibits cultured VSMC proliferation and migration. • Overexpression of N24 arrests the cell cycle at S phase. • N24 interacts with and stabilizes p53 resulting in growth suppression.

Indexed as

Angioplasty, BalloonAnimalsAorta, ThoracicCarotid ArteriesCell CountCell MovementCell ProliferationGene Products, tatMaleMuscle, Smooth, VascularMyocytes, Smooth MuscleNeointimaPeptide FragmentsPhosphatidylinositol 3-KinasesRats, Sprague-DawleyTumor Suppressor Protein p53Gene Products, tatN24 peptide, humanPeptide FragmentsPhosphatidylinositol 3-KinasesPIK3R3 protein, humanTumor Suppressor Protein p53MigrationNeointimal formationp55γProliferationRestenosisVascular smooth muscle cells

Identifiers

PMID25894383
OpenAlexW2031774034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.